SCHEDULE: Vanguard Reports 7.5% Stake in Kenvue Inc.

Vanguard Capital Management has disclosed beneficial ownership of 143,924,768 shares, representing 7.5% of Kenvue Inc.'s common stock as of March 31, 2026.

Summary

• Vanguard Capital Management, along with its affiliates, has reported beneficial ownership of 143,924,768 shares of Kenvue Inc. common stock.
• This holding represents 7.5% of the total class of securities.
• The filing indicates Vanguard has sole voting power over 19,500,731 shares and sole dispositive power over 143,924,768 shares.
• The reporting date for this ownership stake is March 31, 2026.
• The filing is made under Schedule 13G, indicating Vanguard is an investment adviser and not seeking to control Kenvue.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. It's a standard disclosure of institutional ownership without new strategic information or performance data.

Positives

• Vanguard's significant stake suggests confidence in Kenvue's long-term prospects.
• The filing confirms Vanguard's role as a passive investor, not seeking control, which can be viewed positively by existing management and shareholders.
• The clear disclosure of ownership provides transparency to the market.

Negatives

• A large institutional holder like Vanguard could potentially divest a significant portion of its holdings, impacting share price.

Risks

• While Vanguard is an investment adviser, any substantial shift in its holdings could impact Kenvue's stock price.
• The filing does not detail specific reasons for the investment, leaving potential strategic motivations open to interpretation.

Future Outlook

The filing itself does not contain forward-looking statements or guidance from Kenvue Inc. It solely reports Vanguard's current ownership stake.

Industry Context

StockSavvy.ai notes that a Schedule 13G filing by a major asset manager like Vanguard typically signifies a passive investment. This is common in the consumer health sector where large funds often hold diversified portfolios. Kenvue Inc. operates in a competitive landscape, and significant institutional ownership can signal stability and investor interest.

Comparison to Industry Standards

• Vanguard's ownership of 7.5% in Kenvue Inc. is a substantial stake for an institutional investor, aligning with typical holdings in large-cap consumer staples and healthcare companies.
• Many large asset managers, such as BlackRock and State Street, also hold significant positions in comparable companies within the consumer health sector, often ranging from 3% to 10%.
• The reporting of sole voting and dispositive power is standard for investment advisers managing pooled funds and client accounts.

Stakeholder Impact

• Shareholders: Increased transparency regarding a major institutional investor's stake, potentially influencing market perception.
• Management: Confirmation of a significant passive investor, which generally implies no immediate pressure for control changes.
• Creditors: No direct impact as this filing relates to equity ownership.

Next Steps

• Vanguard will continue to monitor its investment in Kenvue Inc.
• Kenvue Inc. will continue its business operations as disclosed in its other SEC filings.

Key Dates

Keywords

Kenvue Inc, Vanguard Capital Management, Schedule 13G, Common Stock, Beneficial Ownership, Investment Adviser, SEC Filing, Shareholder